Cargando…
Modeling synthetic lethality
BACKGROUND: Synthetic lethality defines a genetic interaction where the combination of mutations in two or more genes leads to cell death. The implications of synthetic lethal screens have been discussed in the context of drug development as synthetic lethal pairs could be used to selectively kill c...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592713/ https://www.ncbi.nlm.nih.gov/pubmed/18789146 http://dx.doi.org/10.1186/gb-2008-9-9-r135 |
_version_ | 1782161563527938048 |
---|---|
author | Le Meur, Nolwenn Gentleman, Robert |
author_facet | Le Meur, Nolwenn Gentleman, Robert |
author_sort | Le Meur, Nolwenn |
collection | PubMed |
description | BACKGROUND: Synthetic lethality defines a genetic interaction where the combination of mutations in two or more genes leads to cell death. The implications of synthetic lethal screens have been discussed in the context of drug development as synthetic lethal pairs could be used to selectively kill cancer cells, but leave normal cells relatively unharmed. A challenge is to assess genome-wide experimental data and integrate the results to better understand the underlying biological processes. We propose statistical and computational tools that can be used to find relationships between synthetic lethality and cellular organizational units. RESULTS: In Saccharomyces cerevisiae, we identified multi-protein complexes and pairs of multi-protein complexes that share an unusually high number of synthetic genetic interactions. As previously predicted, we found that synthetic lethality can arise from subunits of an essential multi-protein complex or between pairs of multi-protein complexes. Finally, using multi-protein complexes allowed us to take into account the pleiotropic nature of the gene products. CONCLUSIONS: Modeling synthetic lethality using current estimates of the yeast interactome is an efficient approach to disentangle some of the complex molecular interactions that drive a cell. Our model in conjunction with applied statistical methods and computational methods provides new tools to better characterize synthetic genetic interactions. |
format | Text |
id | pubmed-2592713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25927132008-12-03 Modeling synthetic lethality Le Meur, Nolwenn Gentleman, Robert Genome Biol Research BACKGROUND: Synthetic lethality defines a genetic interaction where the combination of mutations in two or more genes leads to cell death. The implications of synthetic lethal screens have been discussed in the context of drug development as synthetic lethal pairs could be used to selectively kill cancer cells, but leave normal cells relatively unharmed. A challenge is to assess genome-wide experimental data and integrate the results to better understand the underlying biological processes. We propose statistical and computational tools that can be used to find relationships between synthetic lethality and cellular organizational units. RESULTS: In Saccharomyces cerevisiae, we identified multi-protein complexes and pairs of multi-protein complexes that share an unusually high number of synthetic genetic interactions. As previously predicted, we found that synthetic lethality can arise from subunits of an essential multi-protein complex or between pairs of multi-protein complexes. Finally, using multi-protein complexes allowed us to take into account the pleiotropic nature of the gene products. CONCLUSIONS: Modeling synthetic lethality using current estimates of the yeast interactome is an efficient approach to disentangle some of the complex molecular interactions that drive a cell. Our model in conjunction with applied statistical methods and computational methods provides new tools to better characterize synthetic genetic interactions. BioMed Central 2008 2008-09-12 /pmc/articles/PMC2592713/ /pubmed/18789146 http://dx.doi.org/10.1186/gb-2008-9-9-r135 Text en Copyright © 2008 Le Meur and Gentleman; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Le Meur, Nolwenn Gentleman, Robert Modeling synthetic lethality |
title | Modeling synthetic lethality |
title_full | Modeling synthetic lethality |
title_fullStr | Modeling synthetic lethality |
title_full_unstemmed | Modeling synthetic lethality |
title_short | Modeling synthetic lethality |
title_sort | modeling synthetic lethality |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592713/ https://www.ncbi.nlm.nih.gov/pubmed/18789146 http://dx.doi.org/10.1186/gb-2008-9-9-r135 |
work_keys_str_mv | AT lemeurnolwenn modelingsyntheticlethality AT gentlemanrobert modelingsyntheticlethality |